Back to top


Jazz Pharmaceuticals, Inc. (JAZZ - Analyst Report) has an amazing chart, recently jumping into a new all-time high while the market traded lower on uncertainty in the Euro zone. With an average earnings surprise of 7% over the last four quarters and bullish 30% growth projection, this Zacks #1 Rank stock plays a tune for momentum.

Company Description

Jazz Pharmaceuticals, Inc. develops and commercializes pharmaceutical products with an emphasis in epilepsy and narcolepsy. The company was founded in 2003 and has a market cap of $1.91 billion.

Very few stocks have held up in the tough market of the last few months. Put Jazz at the top of that list, recently spiking into a new all-time high on awesome Q2 results from late July and rising estimates.

Second-Quarter Results

Revenue for the period was up 58% from last year to $65 million. Earnings also came in strong at 75 cents, 9% ahead of the Zacks Consensus Estimate, where the company has an average earnings surprise of 7% over the last four quarters.

The good quarter was driven by the company's narcolepsy drug, Xyrem, where sales were up 67% from last year to $56 million.

Financial Profile

Jazz has been able to use its earnings momentum to strengthen its financial profile, with cash and short-term investments jumping to $102 million from just $10 million last year.


We saw some pretty solid movement in estimates off the good quarter, with the current year adding 22 cents in the last month to $3.10. The next-year estimate is pegged at $4.03, a bullish 30% growth projection.


But in spite of the gains, the valuation picture still looks compelling, with a PEG ratio of .47 well below the benchmark of 1 for value.

12-Month Chart

On the chart, shares recently jumped into a new all-time high on the strong earnings momentum. Look for support from the long-term trend, take a look below.

Michael Vodicka is the Momentum Stock Strategist for He is also the Editor in charge of the Zacks Momentum Trader Service.

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
SIGNET JEWE… SIG 116.37 +7.72%
INSITE VISI… INSV 0.30 +7.11%
CHYRONHEGO… CHYR 2.72 +5.84%
US SILICA H… SLCA 70.72 +4.00%
MALLINCKROD… MNK 80.11 +2.32%